Assay Service for assessing ADME properties and in vivo PK properties with the selected vendor. ENAMINE US INC
Overview
- Response deadline
- 9:00 AM EDT
- Posted
- September 18, 2026
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- No Set aside used
- NAICS
- 424690: Other Chemical and Allied Products Merchant Wholesalers
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH OLAO
- Place of performance
- Bethesda, Maryland, 20892
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 75N98026Q01193ENAMINEUSINCPCANIAAA08396
- Notice ID
- 33f918c6716e4e99852469db864962f0
Description
The Section on Medicinal Chemistry (SMC) develops new molecular entities with implications in improving health and treatment for various metabolic and alcohol associated diseases. To assess the translational potential of novel molecular entities, which would allow us to make decisions to proceed the compounds for further development we utilize multiple derisking assays. These assays comprise of both cell-based (in vitro) testing and then eventually in mice to assess pharmacokinetic parameters to see if the drug is orally available.
Request to procure Chemical Reagent (Assay) Development & Laboratory Testing Service SMC to produce grouped ADME assays and perform a Pharmacokinetic study in C57BL6 mice. By including the Caco-2 Permeability Assay in our ADME evaluation it'll accurately predict the oral absorption potential of our compounds. This well-established in vitro model closely mimics the human intestinal epithelium, providing critical insights into a compound’s passive diffusion, active transport, and efflux processes, such as those mediated by P-glycoprotein (P-gp). The data generated from this assay are vital for informing structure-activity relationship (SAR) optimization, improving compound permeability, and reducing transporter-related liabilities that could hinder bioavailability
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
Files (1)
- Download
SOW ENAMINE US INC.pdf
254 KBAdded in Combined Synopsis/Solicitation version 1Posted
Lifecycle
- 1Version 1Combined Synopsis/SolicitationArchived
Assay Service for assessing ADME properties and in vivo PK properties with the selected vendor. ENAMINE US INC
- 2Version 2Combined Synopsis/SolicitationCancelledArchivedCurrent
Assay Service for assessing ADME properties and in vivo PK properties with the selected vendor. ENAMINE US INC
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N98026Q01193ENAMINEUSINCPCANIAAA08396
Archive Date
Sep 20, 2026
Office Address
BETHESDA, MD, 20892